Why are Calcineurin Inhibitors Relevant to Neonatal Disorders?
In the context of neonatal disorders, CNIs may be used to treat specific conditions that involve immune dysregulation or inflammation. Conditions such as neonatal lupus, certain types of neonatal nephrotic syndrome, and severe atopic dermatitis may benefit from the immunosuppressive properties of CNIs. Their use, however, must be carefully monitored due to the unique physiology and vulnerability of neonates.
